Reteplase
Top View
- Fight Night! a 2021 Stroke Debate
- Thrombolysis with Reteplase in Acute Pulmonary Embolism
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- * Thromboembolic Disease Antithrombotic Therapy for Venous
- Antithrombotic Therapy in Patients with Acute Coronary Syndromes
- Evaluation of Efficacy and Safety of Reteplase and Alteplase in The
- Statistics on Medicines Consumption 2009
- Effects of Reteplase and Alteplase on Platelet Aggregation and Major Receptor Expression During the First 24 Hours of Acute Myocardial Infarction Treatment
- Therapeutic Effect Evaluation of Reteplase on Acute Pulmonary Embolism
- Rapilysin, INN-Reteplase
- Drug Repositioning and Indication Discovery Using Description Logics
- Lovenox EMEA-H-A-30-1429
- Rapilysin, INN-Reteplase
- HEPARIN SODIUM 100 I.U./Ml FLUSHING SOLUTION for MAINTENANCE of PATENCY of INTRAVENOUS DEVICES
- In-AMI Trial
- ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
- Guidelines for ATC Classification and DDD Assignment 2021
- Anticoagulants: the Quick Guide to Use and Reversal